77992-44-0Relevant articles and documents
Compound and application thereof
-
Paragraph 0126-0130, (2021/11/10)
The invention provides a compound and application thereof. The compound has a structure as shown in a formula I, and is used as a material of an electron transport layer in an organic electroluminescent device. The organic electroluminescent device comprises a first electrode, a second electrode and an organic layer between the first electrode and the second electrode, wherein the organic layer contains any one or a combination of at least two of the compounds. The compound has relatively high electron injection and migration performance. When the compound is used as an electron transport layer material in an organic electroluminescent device, the luminous efficiency of the device can be improved, and the starting voltage of the device can be reduced.
CD206 MODULATORS THEIR USE AND METHODS FOR PREPARATION
-
Paragraph 0263, (2021/06/26)
Compounds of Formula I, Formula II, and Formula III and the pharmaceutically acceptable salts thereof are disclosed. The variables X, a, b, c, d, R1-4, R10-15 and R17-22 are disclosed herein. The compounds are useful for treating cancer disorders, especially those involving M2 phenotype of macrophages. Pharmaceutical compositions containing compounds of Formula I or Formula II or Formula III and methods of treatment comprising administering compounds of Formula I and Formula II and Formula III are also disclosed.
TRIAZOLOPYRIDIN-3-ONES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
-
Paragraph 018-0184, (2020/07/07)
The present technology provides triazolopyridin-3-ones or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. The triazolopyridin-3-ones or their pharmaceutically acceptable salts exhibit inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).